A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.
Market Scope
Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis
Latest Reports Latest News
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Exclusive manufacturer-reported metrics
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Physician Surveys
For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.
Complete a Survey
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark Your Performance
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
View Market Insights & Analytics
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register Today
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 100
Comprehensive Pages
- 48
Transactions in 2018
- 70
Transactions in 2017
- 21
Venture Capital Firms
Latest Industry News & Trends
10/11/2018
orthopedicpress release
Market Scope Announces Launch of New Website and Entry into Orthopedics
.jpg)
Market Scope, an industry leader for ophthalmic market research, announced today the launch of its new website and the firm’s entry into orthopedics, its second medical vertical. The new Market-Sco...
12/7/2018
breakingophthalmic
Shareholders Approve Takeda’s $62 Billion Acquisition of Shire
Shareholders voted Dec. 5 to approve Takeda’s proposed $62 billion acquisition of Shire. Eighty-eight percent of Takeda’s shareholders voted in favor of the acquisition. More than 99 percent of Shi...
12/7/2018
breakingophthalmic
US FDA to Modernize 510(k), De Novo Review Processes for Medical Devices
The US FDA plans to modernize the 510(k) and De Novo pathways for reviewing new medical devices. The 510(k) pathway, established in 1976, compares new technology with predicate, or existing, device...
12/7/2018
breakingophthalmic
US FDA Clears Ocular Therapeutix’ Dextenza for Post-Surgery Ocular Pain
The US FDA has cleared Ocular Therapeutix’ Dextenza 4 mg for intracanalicular use for the treatment of ocular pain following ophthalmic surgery, the company announced Dec. 3. Dextenza is a corticos...
12/7/2018
breakingophthalmic
Spark Pioneers Win $1 Million Sanford Lorraine Cross Award
Two women whose work contributed to the creation of Spark Therapeutics’ Luxturna have been awarded the inaugural $1 million Sanford Lorraine Cross Award, Sanford Health announced Dec. 6. Jean Benne...
12/7/2018
breakingophthalmic
ProQR Announces IND Clearance, Trial for Usher Syndrome Type 2 Candidate
The US FDA has cleared ProQR Therapeutics’ Investigational New Drug (IND) application for QR-421a, the Netherlands-based company announced Dec. 4. QR-421a is a first-in-class investigational RNA-ba...
12/7/2018
breakingophthalmic
Plex to Advance Topical Candidate for Cataracts to In Vivo Animal Studies
Plex Pharmaceuticals announced Dec. 3 that it plans to advance CAP1160, a topical treatment candidate for cataract disease, to in vivo animal studies. San Diego-based Plex (formerly CalAsia Pharmac...
12/7/2018
breakingophthalmic
Leiters Awarded Service Agreement with Premier that Includes Compounded Avastin
Leiters announced Dec. 3 that it has been awarded a three-year service agreement with Premier, a health care improvement company, which includes providing compounded Avastin. Premier has an allianc...
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.